Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The poliovirus type 3 capsid protein VP1 is a major structural component of the viral icosahedral capsid, which consists of 60 copies each of VP1, VP2, VP3, and VP4. VP1 features an eight-stranded antiparallel beta-barrel core decorated with loops and extensions that contribute to the canyon surrounding the fivefold axis on the capsid surface, where the poliovirus receptor (PVR) binds by inserting its domain 1 into this depression.[1][8] This interaction triggers conformational changes leading to the 135S particle intermediate, externalizing the N-terminus of VP1 and VP4 to facilitate membrane insertion and viral RNA release during cell entry.[2][3] The N-terminal extension of VP1, predicted to form an amphipathic helix, associates with host cell membranes, potentially forming a translocation pore for the genome.[2][3] A hydrophobic pocket within VP1's core often contains a "pocket factor" that stabilizes the capsid, and mutations in VP1 loops can alter receptor usage, stability, or drug resistance.[1][3] VP1 plays a critical role in poliovirus pathogenesis by enabling infection of motor neurons, leading to poliomyelitis.[4] Although no small-molecule drugs directly target VP1 clinically, its structure has informed antiviral strategies like pocket-binding compounds in related enteroviruses.[3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poliovirus type 3 capsid protein VP1 (VP1).